Fact CheckerSign in

NCT05031819Completed

Managing Hypertension Among People Living With HIV

Managing Hypertension Among People Living With HIV: An Integrated Model (MAP-IT)

Source: ClinicalTrials.gov · Last updated 21 Nov 2025

Brief summary (registry, in English)

The Managing Hypertension Among People Living with HIV: An InTegrated Model (MAP-IT) a stepped wedge, cluster-randomized controlled trial to evaluate the effect of practice facilitation (PF) on the integration of a Task-Shifting Strategy for hypertension (HTN) control (TASSH) into HIV care for management of HTN in people living with HIV (PLWH). The study will recruit 960 PLWH across 30 primary health centers (PHCs) in Akwa Ibom State (32 patients/PHC).

Status (registry)
Completed
Study type
Interventional
Enrollment
960 (actual)
First submitted
27 Aug 2021
Start date
26 Oct 2022
Primary completion date
30 Apr 2025
Lead sponsor
Dr. Dike Ojji
NCT number
NCT05031819

What you commit to

  • Study type: Interventional
  • Participants enrolled: 960
  • From 26 Oct 2022 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known history of kidney disease, heart disease, diabetes mellitus, stroke

Other

  • BP ≥180/100 mm Hg
  • A female who is pregnant or breastfeeding at the time of enrollment
  • Inability to provide informed consent
  • Refusal to participate in the study

Who the study is looking for

  • Persons aged 18 years or older
  • Be HIV positive and currently enrolled in HIV treatment services at one of the 30 study PHCs, be receiving HTN treatment services at one of the 30 study PHCs, or can be enrolled at one of the 30 study PHCs to receive HTN services for the entire study duration.
  • Have elevated blood pressure between 140-179 mm Hg systolic and/or 90-109 mm Hg diastolic, as determined by the average of the latter two of three separate BP readings during one clinic visit
  • Able to provide consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Primary Health Care Facilities
Coordinator of this site? Confirm its status
UyoNigeriaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.